Video

Dr. Scarlett Gomez discusses prostate genomic testing in a world of precision medicine

Video Player is loading.
Current Time 0:00
Duration 4:45
Loaded: 3.44%
Stream Type LIVE
Remaining Time 4:45
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    In this video, Scarlett Gomez, MD, PhD, discusses the background and findings of the study, “Active surveillance for watchful waiting in clinically low-risk prostate cancer patients in the SEER database with and without an Oncotype DX genomic prostate score assay,” presented at the 2021 American Urological Association Annual Meeting. Gomez is a professor in the department of epidemiology and biostatistics at the University of California, San Francisco.

    © 2025 MJH Life Sciences

    All rights reserved.